In 2026, the manufacturer's list price for brand-name Wegovy (semaglutide) is about $1,350 a month. Most people don't pay that, but what you actually pay depends a lot on how you buy it. Elara's compounded semaglutide program starts at $247 a month, all-inclusive, and drops to about $198 a month on the 12-month plan. Below is the real math, with no fine print.
Key takeaways
- Brand Wegovy's list price is about $1,350/month. The maker's own cash-pay pharmacy (NovoCare) now offers it for around $349/month for the medication alone.
- Elara's compounded semaglutide starts at $247/month and includes the provider visit, the medication, shipping, ongoing support from the medical team, and the app.
- Compounded medications are not FDA-approved. Brand Wegovy is FDA-approved for chronic weight management. These are different products, see below.
- "All-inclusive" is the number that matters. Some programs quote a low medication price, then add consult fees, lab fees, a membership charge, or raise the price as your dose goes up.
- Elara is cash-pay, so there are no insurance prior authorizations, coverage checks, or denials to work around.
How much does semaglutide cost per month in 2026?
There are four common ways to pay for semaglutide, and the real-world price ranges from about $198 to about $1,350 a month depending on which you choose.
| How you buy it | Product | Typical 2026 price | What's included | FDA-approved? |
|---|---|---|---|---|
| Brand Wegovy, list price | Branded semaglutide | ~$1,350/mo | Medication only | Yes, for chronic weight management |
| Brand Wegovy, through insurance | Branded semaglutide | Varies widely; often not covered for weight loss | Depends on your plan | Yes |
| Brand Wegovy, NovoCare self-pay | Branded semaglutide | ~$349/mo (lower intro for the first 2 months) | Medication only, you still need a prescriber | Yes |
| Elara compounded semaglutide | Compounded semaglutide | From $247/mo → ~$198/mo (12-mo plan) | Provider visit, medication, shipping, support, app | No, not FDA-approved |
A few notes on that table. The $1,350 list price is the sticker price the manufacturer publishes; almost no one pays it directly. Through NovoCare's self-pay pharmacy, Novo Nordisk sells brand Wegovy for about $349 a month (with a lower introductory price for the first two fills), but that price covers the medication only, you still need a separate prescription and provider. Elara's compounded semaglutide is a different product at a different price point, and the number you see is genuinely all-in.
Brand vs. compounded: what you're actually comparing
Be clear-eyed about this, because it's the part most price comparisons blur. Brand Wegovy and compounded semaglutide are not the same product.
Wegovy is the FDA-approved, brand-name finished drug, tested and approved for chronic weight management in adults who meet the criteria. Compounded semaglutide is prepared by a state-licensed compounding pharmacy and prescribed by a licensed clinician when it's appropriate for you. It is not the branded drug, and it is not FDA-approved.
Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality.
So the honest comparison isn't "the same thing for less." It's a comparison of price and access: brand Wegovy lists around $1,350 a month; Elara's compounded semaglutide program starts at $247 a month, all-in. You weigh that difference against the fact that the compounded product is not FDA-approved, and a licensed provider helps you decide what fits your situation.
One more point worth clearing up, because women searching on price often mix these up: Ozempic also contains semaglutide, but Ozempic is FDA-approved for type 2 diabetes, not weight loss. Using it for weight loss is off-label. Wegovy is the semaglutide product that carries the FDA's weight-management approval.
What does "all-inclusive" mean at Elara, and what hidden fees should you check for elsewhere?
At Elara, one price covers everything: the provider visit, the medication, shipping to your door, ongoing access to the medical team after your prescription, the private community, and the app. There is no separate membership fee.
Here are Elara's compounded semaglutide plans:
| Plan | Total price | Works out to |
|---|---|---|
| Monthly | $247 | $247/mo |
| Quarterly (3 months) | $590 | $197/mo |
| 6-month | $1,190 | $198/mo |
| 12-month | $2,380 | $198/mo |
The longer plans lower the monthly cost because they're billed up front, the same medication and care, spread across more months.
When you shop around, the headline number is rarely the whole number. Before you compare prices anywhere, ask whether the quote includes:
- The provider visit / consultation, some services bill this separately.
- The medication at every dose, some prices climb as your dose is titrated up over time.
- Shipping, often added at checkout.
- A membership or subscription fee stacked on top of the medication.
- Lab work, if it's required.
- Follow-ups and messaging with the medical team.
- Cancellation or restart fees.
That checklist isn't hypothetical. In December 2025, the FTC finalized an order against telehealth GLP-1 seller NextMed over undisclosed costs and membership commitments (among other deceptive practices), requiring refunds to consumers. Hidden fees are exactly what "all-inclusive" is meant to prevent.

Why is compounded semaglutide less expensive than brand Wegovy?
Two honest reasons, and neither is that it's "the same medication for less."
First, it's a different product with a different pricing model. Brand Wegovy's price reflects a patented, FDA-approved drug from a large manufacturer. Compounded semaglutide is made by state-licensed compounding pharmacies and priced differently. It is not FDA-approved.
Second, Elara's price is cash-pay and bundled. There's no insurance middleman, no separately billed visit, and no membership add-on, so the number you see is the number you pay. Cutting that overhead, not cutting corners, is where a large part of the difference comes from.
You may have read that compounded GLP-1s were widely available "because of a shortage." That framing is out of date: the FDA declared the semaglutide shortage resolved in February 2025, and mass shortage-based compounding wound down that year. Today, narrow, patient-specific compounding under section 503A continues where a licensed clinician documents a clinical need for you individually. (Separately, in April 2026 the FDA proposed excluding semaglutide from the 503B "bulks" list used by large outsourcing facilities; the comment period was extended to July 30, 2026. That's a proposal, not a final rule, this area is still moving.)
Does insurance cover semaglutide for weight loss?
Sometimes, but often not, and rarely without hoops. Coverage for GLP-1s prescribed specifically for weight loss is inconsistent: many commercial plans exclude it, traditional Medicare has generally not covered anti-obesity drugs for weight alone, and even plans that do cover it often require prior authorization or step therapy first. It's common for a plan to cover semaglutide for diabetes but not the same molecule for weight management. Always check your specific plan.
This is where cash-pay is a feature, not a compromise. With Elara, there's nothing to pre-authorize, no coverage to verify, and no denial to appeal. You know the price up front, and it doesn't change based on what an insurer decides. For a lot of women, especially anyone who's already been denied coverage for a weight-management drug, that predictability is the point.
Is cheaper compounded semaglutide safe and legitimate?
Lower cost and "legit" are not opposites, but how it's provided is what matters. Legitimate care means a licensed provider reviews every patient, the medication comes from a US state-licensed pharmacy, pricing is transparent and all-in, and you have real human support and clear safety information. Red flags to walk away from: "no prescription needed," no way to reach a provider, "research use only" products, miracle promises, or fees that appear after you've paid.
Because this is a prescription medication, the safety basics apply no matter where you get it:
Safety note. Semaglutide carries a boxed warning for the risk of thyroid C-cell tumors. It is contraindicated if you or a family member have had medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Other important cautions include pancreatitis, gallbladder problems, and significant gastrointestinal side effects. GLP-1s are not recommended in pregnancy or while breastfeeding. This is not the full list, review the FDA prescribing information and talk to a licensed provider about whether semaglutide is right for you.
How Elara helps
If price transparency is what you're after, that's the whole idea behind how Elara prices its program. Compounded semaglutide starts at $247/month, all-in, the provider visit, the medication, shipping, ongoing access to the medical team, and the app, with no separate membership fee. A licensed provider reviews every patient (synchronously or asynchronously depending on your state and case), Elara serves all 50 states plus Puerto Rico, and support is available 7 days a week.
**See Elara's compounded semaglutide plans, from $247/month, all-in.** Or take the free eligibility check; a licensed provider reviews every patient. Compounded medications are not FDA-approved.
For the fuller picture, compare the numbers for the other molecule in our tirzepatide cost breakdown, learn what to look for when buying semaglutide online, and read the current legal status of compounded semaglutide in 2026.
Frequently asked questions
How much does semaglutide cost per month? It depends on how you buy it. Brand Wegovy's list price is about $1,350/month, and the maker's self-pay pharmacy offers it for roughly $349/month (medication only). Elara's compounded semaglutide starts at $247/month, all-inclusive, and works out to about $198/month on the 12-month plan.
Why is compounded semaglutide cheaper than brand Wegovy? It's a different product with a different pricing model, compounded semaglutide is made by state-licensed compounding pharmacies and is not FDA-approved, unlike brand Wegovy. Elara's price is also lower because it's cash-pay and bundled, with no insurance overhead or separate membership fee. It is not "the same drug for less."
Does insurance cover semaglutide for weight loss? Often not, and usually not without hurdles. Many commercial plans exclude GLP-1s for weight loss, traditional Medicare generally hasn't covered anti-obesity drugs, and covered plans often require prior authorization. Check your specific plan. Elara is cash-pay, so there's no coverage to verify and no denial to appeal.
What's included in Elara's price? Everything. One all-inclusive price covers the provider visit, the medication, shipping, ongoing access to the medical team after your prescription, the private community, and the app. There is no separate membership fee, and the price doesn't rise as your dose changes.
Is cheaper compounded semaglutide safe and legitimate? Lower cost isn't the risk, how it's provided is. Look for a licensed provider who reviews every patient, medication from a US state-licensed pharmacy, transparent all-in pricing, and real support. Avoid "no prescription needed" or "research use only" sellers. Compounded semaglutide is not FDA-approved; talk to a licensed provider.
The bottom line
Brand Wegovy lists around $1,350 a month, though the manufacturer's own self-pay price is closer to $349 for the medication alone. Elara's compounded semaglutide starts at $247 a month, all-inclusive, provider visit, medication, shipping, and support in one transparent price. Compounded medications are not FDA-approved, so talk with a licensed provider about what fits your health and your budget.
References
- NovoCare. Wegovy (semaglutide) Cost, Coverage & Savings Resources. https://www.novocare.com/patient/medicines/wegovy.html
- U.S. Food & Drug Administration / DailyMed. Wegovy (semaglutide) Prescribing Information, Boxed Warning: Risk of Thyroid C-Cell Tumors. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
- U.S. Food & Drug Administration. FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize
- U.S. Food & Drug Administration. FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide on 503B Bulks List. https://www.fda.gov/news-events/press-announcements/fda-proposes-exclude-semaglutide-tirzepatide-and-liraglutide-503b-bulks-list
- Federal Trade Commission. FTC Approves Final Order Against Telehealth Provider NextMed Over Charges It Used Deceptive Advertising Claims to Sell GLP-1 Weight-Loss Programs (Dec. 3, 2025). https://www.ftc.gov/news-events/news/press-releases/2025/12/ftc-approves-final-order-against-telehealth-provider-nextmed-over-charges-it-used-deceptive
This article is for general education and is not medical advice. Talk to a licensed clinician about your situation.
Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality.
